Towards Light Activated Ruthenium‐Arene (RAPTA‐type) Prodrug Candidates

ChemBioChem - Germany
doi 10.1002/cbic.201900236
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Towards the Synthesis of Supramolecular Polygons and Polyhedra Containing the Ruthenium-Η6-Arene Unit

Acta Crystallographica Section A Foundations of Crystallography
2004English

Thermoresponsive Organometallic Arene Ruthenium Complexes for Tumour Targeting

Chemical Science
Chemistry
2014English

Ruthenium-Arene Complexes With NSAIDs: Synthesis, Characterization and Bioactivity

New Journal of Chemistry
CatalysisMaterials ChemistryChemistry
2018English

Enhanced Antimetastatic Activity of the Ruthenium Anticancer Drug RAPTA-C Delivered in Fructose-Coated Micelles

Macromolecular Bioscience
PlasticsPolymersMaterials ChemistryBiomaterialsBioengineeringBiotechnology
2017English

Layered Compounds Based on Molybdenum Disulfide and Ruthenium Arene Complexes

Journal of Materials Chemistry
1997English

Inhibition of Cathepsin Activity in a Cell-Based Assay by a Light-Activated Ruthenium Compound

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2014English

Radiosensitisation of Human Colorectal Cancer Cells by Ruthenium(II) Arene Anticancer Complexes

Scientific Reports
Multidisciplinary
2016English

6-Deoxyacyclovir: A Xanthine Oxidase-Activated Prodrug of Acyclovir.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1984English

Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy